Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear Cell Renal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05432947
What this trial is testing

68Ga-P16-093 and 18F-FDG PET/CT Imaging in the Same Group of Clear Cell Renal Cell Carcinoma Patients

Who this might be right for
Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 42
Early research (Phase 1)Active Not RecruitingNCT04483778
What this trial is testing

B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

Who this might be right for
Pediatric Solid TumorGerm Cell TumorRetinoblastoma+14 more
Seattle Children's Hospital 68
Early research (Phase 1)Ended earlyNCT02628535
What this trial is testing

Safety Study of MGD009 in B7-H3-expressing Tumors

Who this might be right for
MesotheliomaBladder CancerMelanoma+10 more
MacroGenics 67
Very early researchNot Yet RecruitingNCT07671417
What this trial is testing

Imaging Study in Metastatic Clear Cell RCC.

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
RayzeBio, Inc. 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT07488533
What this trial is testing

Comparing the Combination of Sullumab and Fruquintinib in Postoperative Adjuvant Therapy for High Recurrence Risk Non Transparent Renal Cell Carcinoma

Who this might be right for
Non-Clear Cell Renal Cell Carcinoma
Sun Yat-sen University 40
Early research (Phase 1)Study completedNCT05861778
What this trial is testing

Evaluation of 89Zr-TLX250 PET/CT in Chinese Patients With Indeterminate Renal Masses or Suspected Recurrent Renal Clear Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell CarcinomaSuspected Recurrent Renal Clear Cell CarcinomaRecurrent Renal Cell Cancer
Telix Pharmaceuticals (Innovations) Pty Limited 10
Not applicableNot Yet RecruitingNCT07233668
What this trial is testing

Immediate Versus Deferred Cytoreductive Nephrectomy With Ipilimumab/Nivolumab in mRCC

Who this might be right for
Metastatic Renal Cell Carcinoma ( mRCC)
Seoul National University Hospital 172
Early research (Phase 1)Temporarily pausedNCT06649682
What this trial is testing

68Ga-NYM096/177Lu-NYM096 in Metastatic ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 20
Not applicableStudy completedNCT01107509
What this trial is testing

Pilot Study of Neo-Adjuvant Everolimus to Treat Advanced Renal Cell Carcinoma - Analysis of Biomarkers

Who this might be right for
Carcinoma, Renal Cell
St. Joseph's Healthcare Hamilton 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07578025
What this trial is testing

Zanzalintinib and MO-03 for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy

Who this might be right for
Metastatic Clear Cell Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8
City of Hope Medical Center 34
Not applicableLooking for participantsNCT00001238
What this trial is testing

Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders

Who this might be right for
Kidney CancerUrologic Malignant DisordersRenal Cell Carcinoma+2 more
National Cancer Institute (NCI) 5,000
Testing effectiveness (Phase 2)Study completedNCT03680521
What this trial is testing

Neoadjuvant Sitravatinib in Combination With Nivolumab in Patients With Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
Mirati Therapeutics Inc. 25
Testing effectiveness (Phase 2)Study completedNCT03163667
What this trial is testing

CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC)

Who this might be right for
Clear Cell Renal Cell Carcinoma
Calithera Biosciences, Inc 69
Large-scale testing (Phase 3)Looking for participantsNCT07197580
What this trial is testing

Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC

Who this might be right for
ccRCCRenal Cell Carcinoma (Kidney Cancer)Renal Cell Carcinoma (RCC)+3 more
Telix Pharmaceuticals (Innovations) Pty Limited 40
Early research (Phase 1)Study completedNCT04148937
What this trial is testing

The CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer

Who this might be right for
Advanced Cancer
Eli Lilly and Company 52
Testing effectiveness (Phase 2)Study completedNCT00003657
What this trial is testing

High-dose ICE With Amifostine

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsCarcinoma of Unknown Primary+8 more
Dana-Farber Cancer Institute 24
Large-scale testing (Phase 3)Study completedNCT01120249
What this trial is testing

S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery

Who this might be right for
Kidney Cancer
SWOG Cancer Research Network 1,545
Testing effectiveness (Phase 2)Looking for participantsNCT05267626
What this trial is testing

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Who this might be right for
Advanced Solid TumorMetastatic CancerCutaneous Melanoma+1 more
Aulos Bioscience, Inc. 159
Testing effectiveness (Phase 2)Looking for participantsNCT05263050
What this trial is testing

Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors

Who this might be right for
Metastatic Renal Cell CarcinomaClear-cell Metastatic Renal Cell CarcinomaNeuroendocrine Tumors+1 more
Fox Chase Cancer Center 111
Testing effectiveness (Phase 2)Study completedNCT01896271
What this trial is testing

High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Metastatic Renal Cancer

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
University of Texas Southwestern Medical Center 30
Next Page